China's Hansoh Pharmaceutical jumps most on record on H1 profit growth
BUZZ-China's Hansoh Pharmaceutical jumps most on record on H1 profit growth ** Shares of China's Hansoh Pharmaceutical Group 3692.HK jump 15.4% to HK$36.62, set for biggest one-day pct rise since debut in June 2019
** Stock hits the highest level since May 14 in the third straight session of gain
** Top pct gainer in the Hang Seng Biotech Index .HSBIO, which gains 0.1%
** The oncology and metabolic disease specialist, a Roche ROPC.S partner, reported a near 36% rise in first-half profit, driven by strong growth in sales of innovative medicines and higher investment income
** Hansoh posted net profit of 4.26 billion yuan ($633.90 million) for the six months ended in June, up from 3.13 billion yuan a year earlier and beating HSBC Qianhai Securities forecast of about 2.9 billion yuan
** YTD, stock up 0.6%, while the Hang Seng Biotech Index .HSBIO up 13.9%
(Reporting by Donny Kwok)
Recent news on Hansoh Pharmaceutical
See all newsHansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Deals of the day-Mergers and acquisitions
Factbox: Major drugmakers turn to China for licensing deals
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion (updated)
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion